ESM1 and breast carcinoma: The ESM-1 expression levels were found elevated in the primary tumors compared to the adjacent control tissues of breast cancer patients of TCAGA-BRCA cohort (p < 0.000001, n = 1091) and showed diverse distribution at the metastatic sites compared to primary tumors of breast cancer patients of the metastatic cohort (Figure 6C).